08.11.2012 Views

ELS-tíðindi - október 2002 - Einkaleyfastofan

ELS-tíðindi - október 2002 - Einkaleyfastofan

ELS-tíðindi - október 2002 - Einkaleyfastofan

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

52 <strong>ELS</strong> <strong>tíðindi</strong> 10/02<br />

(21) 6547<br />

(22) 13.9.<strong>2002</strong><br />

(51) H04L<br />

(54) Sjálfvirkt auðkennaverndarkerfi með<br />

fjareftirliti þriðja aðila.<br />

(71) Íslensk erfðagreining ehf.,<br />

Sturlugötu 8, 101 Reykjavík, Íslandi.<br />

(72) Hákon Guðbjartsson, Reykjavík;<br />

Sverrir Karlsson, Kópavogi; Skeggi<br />

Þormar, Reykjavík; Íslandi.<br />

(74) A&P Árnason ehf., Efstaleiti 5, 103<br />

Reykjavík.<br />

(30) 17.3.2000, US, 60/190,262<br />

(85) 13.9.<strong>2002</strong><br />

(86) 13.3.2001, PCT/IB01/00358<br />

(21) 6548<br />

(22) 16.9.<strong>2002</strong><br />

(51) H04L<br />

(54) Snjóflóðavarnarkerfi Eggerts.<br />

(71) Eggert Ólafsson, Jörfa, Kjalarnesi,<br />

116 Reykjavík, Íslandi.<br />

(72) Eggert Ólafsson, Kjalarnesi,<br />

Reykjavík, Íslandi.<br />

(30) Enginn.<br />

(21) 6549<br />

(22) 17.9.<strong>2002</strong><br />

(51) C07D; C07C; A61K<br />

(54) Estrógen gerandefnis/mótlyfs<br />

umbrotsefni.<br />

(71) Pfizer Products Inc., Eastern Point<br />

Road, Groton, Connecticut 06340,<br />

Bandaríkjunum.<br />

(72) Wesley Warren Day; Kim Anne<br />

Johnson; Chandra Aggarwal Prakash;<br />

James Frederick Eggler; Groton,<br />

Connecticut, Bandaríkjunum.<br />

(74) Faktor einkaleyfaskrifstofa, ehf.,<br />

Pósthólf 678, 121 Reykjavík.<br />

(30) 7.4.2000, US, 60/267,198<br />

(85) 17.9.<strong>2002</strong><br />

(86) 19.3.2001, PCT/IB01/00427<br />

(21) 6550<br />

(22) 17.9.<strong>2002</strong><br />

(51) A41D<br />

(54) Fatnaðaröndunarbúnaður sem gerir<br />

mannslíkamanum kleift að anda, og<br />

aðferð til framleiðslu á búnaðinum.<br />

(71) Geox S.p.A., Via Feltrina Centro. 16,<br />

31044 Montebelluna, Località<br />

Biadene (Treviso), Ítalíu.<br />

(72) Mario Polegato Moretti, Crocetta del<br />

Montello, Ítalíu.<br />

(74) Faktor einkaleyfaskrifstofa, ehf.,<br />

Pósthólf 678, 121 Reykjavík.<br />

(30) 24.1.2001, IT, PD01A000016<br />

(85) 17.9.<strong>2002</strong><br />

(86) 18.1.<strong>2002</strong>, PCT/EP02/00472<br />

(21) 6551<br />

(22) 17.9.<strong>2002</strong><br />

(51) C07D<br />

(54) Formlaus torasemíð umbreyting.<br />

(71) Pliva d.d., Ulica grada Vukovara 49,<br />

10000 Zagreb, Króatíu.<br />

(72) Darko Filiç, Zagreb; Miljenko Dumiç,<br />

Zagreb; BoÏena Klepiç, Jastrebarsko;<br />

Aleksandar Danilovski, Rijeka;<br />

Marijan Tudja, Zagreb; Króatíu.<br />

(74) Faktor einkaleyfaskrifstofa, ehf.,<br />

Pósthólf 678, 121 Reykjavík.<br />

(30) 20.3.2000, HU, P20000162A<br />

(85) 17.9.<strong>2002</strong><br />

(86) 2.5.2000, PCT/HR00/00011<br />

(21) 6552<br />

(22) 17.9.<strong>2002</strong><br />

(51) D01C; C12S<br />

(54) Aðferð og búnaður til að verka<br />

plöntutrefjar.<br />

(71) Feyging ehf., Pósthússtræti 7, 101<br />

Reykjavík, Íslandi.<br />

(72) Edgar Guðmundsson, Kópavogi,<br />

Íslandi.<br />

(74) A&P Árnason ehf., Efstaleiti 5, 103<br />

Reykjavík.<br />

(30) Enginn.<br />

(21) 6553<br />

(22) 18.9.<strong>2002</strong><br />

(51) A61K<br />

(54) Kvarnaðar agnir með duldu bragði.<br />

(71) Biochemie Gesellschaft M.B.H.,<br />

A-6250 Kundl, Austurríki.<br />

(72) Franz Xaver Schwarz, Wörgl, Austurríki.<br />

(74) Sigurjónsson & Thor, ehf.,<br />

Skólavörðustíg 16, 101 Reykjavík.<br />

(30) 28.3.2000, AT, A 524/2000<br />

(85) 18.9.<strong>2002</strong><br />

(86) 26.3.2001, PCT/EP01/03409<br />

(21) 6554<br />

(22) 19.9.<strong>2002</strong><br />

(51) A61K; A61P<br />

(54) Ný samsetning af betatálma og<br />

kólesteróllækkandi miðli.<br />

(71) AstraZeneca AB, S-151 85 Södertälje,<br />

Svíþjóð.<br />

(72) Göran Bondjers, Lerum; Olov Wiklund,<br />

Mölndal; John Wikstrand, Mölndal;<br />

Svíþjóð.<br />

(74) Sigurjónsson & Thor, ehf.,<br />

Skólavörðustíg 16, 101 Reykjavík.<br />

(30) 3.4.2000, SE, 0001188-2<br />

22.6.2000, SE, 0002352-3<br />

(85) 19.9.<strong>2002</strong><br />

(86) 27.3.2001, PCT/SE01/00663<br />

(21) 6555<br />

(22) 19.9.<strong>2002</strong><br />

(51) A61K; A61P<br />

(54) Meðferð með aðskildum skömmtum<br />

sem hafa æðaskaðandi virkni.<br />

(71) Angiogene Pharmaceuticals Ltd.,<br />

The Magdalen Centre, The Oxford<br />

Science Park, Oxford OX4 4 GA,<br />

Bretlandi.<br />

(72) Peter David Davis, Watlington,<br />

Oxfordshire, Bretlandi.<br />

(74) Sigurjónsson & Thor, ehf.,<br />

Skólavörðustíg 16, 101 Reykjavík.<br />

(30) 31.3.2000, GB, 0007740.4<br />

8.6.2000, GB, 0013928.7<br />

20.6.2000, GB, 0014904.7<br />

(85) 19.9.<strong>2002</strong><br />

(86) 27.3.2001, PCT/GB01/01329<br />

(21) 6556<br />

(22) 20.9.<strong>2002</strong><br />

(51) C25C<br />

(54) Uppsetning búnaðar rafgreiningarvers<br />

til að framleiða ál.<br />

(71) Aluminium Pechiney, 7, place du<br />

Chancelier Adenauer, F-75218 Paris<br />

Cedex 16, Frakklandi.<br />

(72) Jean-Pierre Boucard, Biviers,<br />

Frakklandi.<br />

(74) Sigurjónsson & Thor, ehf.,<br />

Skólavörðustíg 16, 101 Reykjavík.<br />

(30) 24.3.2000, FR, 00/03813<br />

(85) 20.9.<strong>2002</strong><br />

(86) 19.3.2001, PCT/FR01/00806<br />

(21) 6557<br />

(22) 20.9.<strong>2002</strong><br />

(51) A61K; A61P<br />

(54) Blandaðar sjúkdómsmeðferðir úr<br />

blóðþrýstingslækkandi efnum og<br />

efnum sem hamla æðamyndun.<br />

(71) AstraZeneca AB, S-151 85 Södertälje,<br />

Svíþjóð.<br />

(72) Jon Owen Curwen; Donald James<br />

Ogilvie; Macclesfield, Cheshire,<br />

Bretlandi.<br />

(74) Sigurjónsson & Thor, ehf.,<br />

Skólavörðustíg 16, 101 Reykjavík.<br />

(30) 5.4.2000, GB, 0008269.3<br />

(85) 20.9.<strong>2002</strong><br />

(86) 2.4.2001, PCT/GB01/01522<br />

(21) 6558<br />

(22) 20.9.<strong>2002</strong><br />

(51) A61K; A61P<br />

(54) Blandaðar sjúkdómsmeðferðir með<br />

æðaskaðandi virkni.<br />

(71) Angiogene Pharmaceuticals Ltd.,<br />

The Magdalen Centre, The Oxford<br />

Science Park, Oxford OX4 4 GA,<br />

Bretlandi.<br />

(72) Peter David Davis, Watlington,<br />

Oxfordshire, Bretlandi; Graeme<br />

Dougherty, Los Angeles, California,<br />

Bandaríkjunum.<br />

(74) Sigurjónsson & Thor, ehf.,<br />

Skólavörðustíg 16, 101 Reykjavík.<br />

(30) 31.3.2000, GB, 0007740.4<br />

8.6.2000, GB, 0013927.9<br />

20.6.2000, GB, 0014908.8<br />

(85) 20.9.<strong>2002</strong><br />

(86) 27.3.2001, PCT/GB01/01317<br />

(21) 6559<br />

(22) 20.9.<strong>2002</strong><br />

(51) C07H; A61K; A61P<br />

(54) Notkun á azalíð sýklalyfssamsetningum<br />

til að meðhöndla eða<br />

fyrirbyggja bakteríu- eða frumdýrasýkingu<br />

í spendýrum.<br />

(71) Pfizer Products Inc., Eastern Point<br />

Road, Groton, Connecticut 06340,<br />

Bandaríkjunum.<br />

(72) Wayne Alan Boettner, Groton,<br />

Connecticut; Peter Connor Canning,<br />

Terre Haute, Indiana; Bandaríkjunum.<br />

(74) Faktor einkaleyfaskrifstofa, ehf.,<br />

Pósthólf 678, 121 Reykjavík.<br />

(30) 27.4.2000, US, 60/199,961<br />

(85) 20.9.<strong>2002</strong><br />

(86) 26.3.2001, PCT/IB01/00519

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!